We are live on ! Find out more
T. Rowe Price Investment Management

T. Rowe Price Investment Management Portfolio holdings

AUM $145B
1-Year Est. Return 22.78%
 

T. Rowe Price Investment Management, Inc. (TRPIM), a division of T. Rowe Price Group established in August 2022 and headquartered in Baltimore, Maryland, is an active investment manager overseeing hundreds of billions in assets, focusing on equity and fixed-income strategies for institutional clients and sub-advisory mandates. Spun off from the parent company founded in 1937 by Thomas Rowe Price, Jr., TRPIM operates as a distinct entity with around 900 employees, emphasizing a research-driven, long-term approach rooted in fundamental analysis and disciplined risk management. Managing portfolios like large-cap growth and international equity funds, it complements T. Rowe Price’s broader offerings while targeting sophisticated investors such as pension funds and endowments with tailored, high-conviction solutions. Under the leadership of president Rob Sharps, TRPIM upholds the firm’s legacy of integrity and client focus, adapting its founder’s value-oriented philosophy to modern institutional needs.

This Fund
S&P 500
This Quarter Est. Return
+3.34%
1 Year Est. Return
+22.78%
3 Year Est. Return
+69.87%
5 Year Est. Return
10 Year Est. Return
AUM
$158B
AUM Growth
-$5.16B
Cap. Flow
-$7.02B
Cap. Flow %
-4.43%
Top 10 Hldgs %
22.66%
Holding
961
New
80
Increased
260
Reduced
443
Closed
63

Top Sells

Rank Stock Value
1
DHR icon
Danaher
DHR
+$1.18B
2
HOLX
Hologic
HOLX
+$1.14B
3
CI icon
Cigna
CI
+$1.05B
4
ROP icon
Roper Technologies
ROP
+$918M
5
DTE icon
DTE Energy
DTE
+$834M

Sector Composition

Rank Sector Weight
1 Technology 24.82%
2 Healthcare 20.04%
3 Consumer Discretionary 13.58%
4 Financials 12.54%
5 Industrials 9.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TMO icon
51
Thermo Fisher Scientific
TMO
$223B
$770M 0.49%
1,328,845
+1,270,643
+2,183% +$719M
SPGI icon
52
S&P Global
SPGI
$121B
$756M 0.48%
1,446,633
+1,385,249
+2,257% +$685M
COO icon
53
Cooper Companies
COO
$15B
$742M 0.47%
9,047,117
-779,487
-8% -$58.3M
KDP icon
54
Keurig Dr Pepper
KDP
$40.2B
$728M 0.46%
+25,978,817
New +$713M
NYT icon
55
New York Times
NYT
$10.3B
$727M 0.46%
10,478,896
-234,452
-2% -$14.5M
IONS icon
56
Ionis Pharmaceuticals
IONS
$9.39B
$721M 0.45%
9,108,019
-4,048,910
-31% -$305M
ALNY icon
57
Alnylam Pharmaceuticals
ALNY
$30B
$697M 0.44%
1,753,640
-420,344
-19% -$186M
ACLX
58
DELISTED
Arcellx
ACLX
$689M 0.43%
10,560,425
+4,208,069
+66% +$336M
MPWR icon
59
Monolithic Power Systems
MPWR
$70B
$657M 0.41%
724,494
-26,194
-3% -$25.2M
KEYS icon
60
Keysight
KEYS
$60.6B
$648M 0.41%
3,188,308
-160,823
-5% -$29.8M
TSM icon
61
TSMC
TSM
$2.23T
$636M 0.4%
2,093,115
+1,313,917
+169% +$386M
MCHP icon
62
Microchip Technology
MCHP
$43.1B
$632M 0.4%
9,919,171
+441,868
+5% +$27.3M
TXT icon
63
Textron
TXT
$15.3B
$621M 0.39%
7,128,233
-1,082,127
-13% -$90.5M
WDAY icon
64
Workday
WDAY
$43.3B
$611M 0.39%
2,844,337
-1,202,915
-30% -$273M
FERG icon
65
Ferguson
FERG
$47.4B
$606M 0.38%
2,724,193
-24,222
-0.9% -$5.79M
TRU icon
66
TransUnion
TRU
$15.2B
$604M 0.38%
7,046,378
-9,086
-0.1% -$747K
CCC
67
CCC Intelligent Solutions
CCC
$4.11B
$594M 0.37%
74,672,379
+7,899,716
+12% +$64.3M
ULTA icon
68
Ulta Beauty
ULTA
$22.9B
$589M 0.37%
974,223
+2,463
+0.3% +$1.35M
ODFL icon
69
Old Dominion Freight Line
ODFL
$44.1B
$577M 0.36%
3,680,719
+365,424
+11% +$52.4M
PCTY icon
70
Paylocity
PCTY
$7.73B
$575M 0.36%
3,770,975
-18,542
-0.5% -$2.76M
MLM icon
71
Martin Marietta Materials
MLM
$32.7B
$571M 0.36%
917,565
-136,097
-13% -$84.6M
CBOE icon
72
Cboe Global Markets
CBOE
$30.4B
$559M 0.35%
2,228,571
-151,746
-6% -$37.7M
RJF icon
73
Raymond James Financial
RJF
$34.9B
$555M 0.35%
3,457,716
-185,520
-5% -$30M
BAH icon
74
Booz Allen Hamilton
BAH
$9.43B
$551M 0.35%
6,528,226
+1,811,906
+38% +$162M
VLTO icon
75
Veralto
VLTO
$23.6B
$545M 0.34%
5,461,464
-1,436,785
-21% -$145M

Similar funds

T. Rowe Price Investment Management's Q4 2025 Portfolio in Review

As of Q4 2025, T. Rowe Price Investment Management held 961 positions worth $158B, down 3.2% from $164B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

T. Rowe Price Investment Management withdrew a net $7.02B in Q4 2025, closing 63 positions and reducing 443 holdings. Its most notable exit was Bright Horizons, an estimated $240M position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, T. Rowe Price Investment Management opened a new position in Keurig Dr Pepper worth $728M.

  • T. Rowe Price Investment Management's largest Q4 2025 buy was Keurig Dr Pepper: 25,978,817 shares worth $728M.
  • T. Rowe Price Investment Management added most to Cencora in Q4 2025, an estimated $1.41B increase.
  • T. Rowe Price Investment Management's biggest Q4 2025 reduction was Danaher, cutting an estimated $1.18B.
  • T. Rowe Price Investment Management fully exited Bright Horizons in Q4 2025, selling an estimated $240M.
  • T. Rowe Price Investment Management's ten largest holdings make up 23% of its $158B portfolio in Q4 2025.
  • T. Rowe Price Investment Management opened 80 new positions and closed 63 in Q4 2025.
  • T. Rowe Price Investment Management's portfolio value fell 3.2% quarter-over-quarter to $158B.

Based on T. Rowe Price Investment Management's 13F filing for Q4 2025, filed 17 Feb 2026.